Mental Illness clinical trials at UCSF
1 research study open to eligible people
Showing trials for
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
open to eligible people ages 18 years and up
This is a research study about a smoking cessation program tailored for adults with serious mental illness (SMI). The program uses a Videogame-based Physical (VIP) activity, smoking cessation counseling, and medication (bupropion),
San Francisco, California
Our lead scientists for Mental Illness research studies include Heather Leutwyler, PhD.
Last updated: